Alnylam Pharmaceuticals
ALNY
ALNY
168 hedge funds and large institutions have $3.58B invested in Alnylam Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 61 increasing their positions, 65 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 65
35% less call options, than puts
Call options by funds: $7.17M | Put options by funds: $11.1M
Holders
168
Holding in Top 10
4
Calls
$7.17M
Puts
$11.1M
Top Buyers
| 1 | +$391M | |
| 2 | +$64.3M | |
| 3 | +$38.3M | |
| 4 |
Morgan Stanley
New York
|
+$35.4M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$23.2M |
Top Sellers
| 1 | -$68.2M | |
| 2 | -$27.2M | |
| 3 | -$24.5M | |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$22.4M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$20.7M |